Trial

NCT02315144

An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Collaborators
Condition
Chronic Obstructive Pulmonary Disease
Intervention
TV48108
Why stopped
Business decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-09